Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | QPCT | Q16769 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6686022 | 0.99 | L3MBTL1 (0.58) | L3MBTL1SMN1; SMN2QPCTALDH1A1NPC1 | |
| SCHEMBL16798907 | 0.91 | ALDH1A1 (0.49) | L3MBTL1SMN1; SMN2QPCTALDH1A1NPC1 | |
| SCHEMBL19198443 | 0.90 | IDE (0.51) | L3MBTL1SMN1; SMN2QPCTALDH1A1NPC1 | |
| SCHEMBL21669765 | 0.88 | TBXAS1 (0.52) | L3MBTL1SMN1; SMN2ALDH1A1LMNAPOLB | |
| SCHEMBL13655177 | 0.88 | SMN1; SMN2 (0.72) | L3MBTL1SMN1; SMN2QPCTALDH1A1NPC1 | |
| SCHEMBL21669751 | 0.87 | TBXAS1 (0.54) | L3MBTL1SMN1; SMN2ALDH1A1LMNAPOLB | |
| SCHEMBL21669744 | 0.87 | TBXAS1 (0.54) | L3MBTL1SMN1; SMN2ALDH1A1LMNAPOLB | |
| SCHEMBL21669747 | 0.87 | TBXAS1 (0.54) | L3MBTL1SMN1; SMN2ALDH1A1LMNAPOLB | |
| SCHEMBL21669749 | 0.87 | TBXAS1 (0.54) | L3MBTL1SMN1; SMN2ALDH1A1LMNAPOLB | |
| SCHEMBL21669740 | 0.87 | TBXAS1 (0.54) | L3MBTL1SMN1; SMN2ALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7582684-B2 | Macroporous ion exchange resins | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-09-01 | — | — | US | claimed |
| EP-0707077-B1 | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same | ORTHO CLINICAL DIAGNOSTICS INC (US) | 2004-11-17 | — | — | EP | claimed |
| EP-0702006-B1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLIN DIAG (US) | 2000-05-10 | — | — | EP | claimed |
| US-5582988-A | PRECIPITAION OF NUCLEIC ACID AND CATION POLYMER AT ACIDIC PH; ADJUSTMENT OF PH TO RELEASE NUCLEIC ACID | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-12-10 | — | — | US | claimed |
| US-5523368-A | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-06-04 | — | — | US | claimed |
| EP-0707077-A2 | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0702006-A1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-03-20 | — | — | EP | claimed |
| JP-8173194-A | — | — | None | — | — | JP | disclosed |
| US-12630582-B2 | Method for biomaterial purification and kits thereof | Life Technologies Corporation (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250367610-A1 | Block Copolymers Grafted to Porous Polymeric Substrate | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-12-04 | — | — | US | disclosed |
| CN-114144248-B | Imidazolium zwitterionic polymerizable compounds and ophthalmic devices incorporating same | 强生视力健公司 | 2025-06-03 | — | — | CN | disclosed |
| EP-4543575-A1 | BLOCK COPOLYMERS GRAFTED TO POROUS POLYMERIC SUBSTRATE | Solventum Intellectual Properties Company (US) | 2025-04-30 | — | — | EP | disclosed |
| EP-2588219-B1 | FILTER PLATE ARTICLE HAVING A WATER-ABSORBENT FILTER ASSEMBLY | NEOGEN FOOD SAFETY US HOLDCO CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-0702006-B1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLIN DIAG (US) | 2000-05-10 | — | — | EP | disclosed |
| US-5582988-A | PRECIPITAION OF NUCLEIC ACID AND CATION POLYMER AT ACIDIC PH; ADJUSTMENT OF PH TO RELEASE NUCLEIC ACID | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-12-10 | — | — | US | disclosed |
| JP-H08173194-A | CAPTURE AND SELECTIVE RELEASE OF NUCLEIC ACID USING WEAKLY BASIC POLYMER AND AMPLIFYING OF THE SAME | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS INC | 1996-07-09 | — | — | JP | disclosed |
| US-5523368-A | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-06-04 | — | — | US | disclosed |
| EP-0707077-A2 | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0702006-A1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-03-20 | — | — | EP | disclosed |
| US-5434270-A | Weakly basic polymerizable monomers and polymers prepared therefrom | EASTMAN KODAK COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630582-B2 | Method for biomaterial purification and kits thereof | CD68, FIBP, BMP2 | L3MBTL1 1406/4885SMN1; SMN2 3006/4885QPCT 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.